Nektar Therapeutics | NKTR - Current Assets


Nektar Therapeutics reported $589.04M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agios Pharmaceuticals USD 717.67M 117.18M Jun/2026
ALKERMES USD 1.52B 164.26M Jun/2026
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Amgen USD 34.96B 3.49B Jun/2026
Baxter International USD 6.99B 142M Jun/2026
BioCryst Pharmaceuticals USD 484.68M 111.06M Jun/2026
Biogen USD 7.31B 1.88B Jun/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Cara Therapeutics USD 25.33M 6.21M Mar/2026
Cipla INR 241.47B 7.71B Mar/2026
Dr.Reddys Laboratories INR 299.33B 2.46B Jun/2026
Eisai JPY 883.01B 121.38B Jun/2026
Eli Lilly USD 64.67B 9.84B Jun/2026
Exelixis USD 1.25B 42.18M Jun/2026
Gilead Sciences USD 12.53B 6.11B Jun/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
Grifols EUR 5.96B 316.31M Dec/2025
Halozyme Therapeutics USD 933.02M 70.01M Jun/2026
Incyte USD 6.03B 542.31M Jun/2026
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
Ironwood Pharmaceuticals USD 332.29M 58.11M Mar/2026
Karyopharm Therapeutics USD 126.33M 23.19M Mar/2026
MacroGenics USD 321.69M 139.16M Jun/2026
Merck USD 36.68B 1.66B Jun/2026
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Neurocrine Biosciences USD 1.64B 798.6M Jun/2026
Novartis USD 27.35B 744M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sarepta Therapeutics USD 2.22B 86.05M Jun/2026
Takeda JPY 3.15T 59.77B Jun/2026
Teva Pharmaceutical Industries USD 13.76B 50M Jun/2026
Xencor USD 523.21M 40.36M Jun/2026